Healthtech specialist investing pre-seed to seed+ tickets of €200k–€1.5M in IT-driven healthcare transformation across Europe, the US, Israel, Canada and Australia, leading or co-investing, and avoiding drug and vaccine development.
See which investors fit your startup
Add your website. We pick three investors who back companies at your stage, sector and market, with the evidence for each.
Published mandate
Stage: Pre-seed, Seed
Cheque: €200K–€1.5M (≈ $224K–$1.7M)
Geography: Europe, US, Israel, Canada, Australia / New Zealand
Sectors: Health
Converted at ECB reference rate, 9 Oct 2026
Sources
Sources checked 2026-10-11.
Verified on the fund's own site
Related investor lists
Check before outreach
From shortlist to first meeting
Everything in Launch, plus help with the first email and the first call.
- Deck review
- First emails built on each investor's recent deals
- Meeting prep, phone numbers and CSV export